K

Kiniciti

10 employees

Kiniciti is a new WCAS platform established to partner with companies that have the potential to transform the cell and gene therapy

Investor insights

Sectors invested in

Pharmaceutical1
Health Care1
Biotechnology1
Medical1
drug discovery1
drug development1
cell based assays1
safety pharmacology1
cardiomyocytes1
iPSC cells1

Funding rounds participated in

$60M sweet spot round size

Most of their 1 investments are in rounds between $60M and $60M

Investor type

Private Equity Firm

Basic info

Industry

biotechnology research

Sectors

Life Sciences
Finance
Cell & Gene Therapy
Genetics
Medical
Drug Manufacturing
Drug Development
Drug Delivery
Venture Capital

Date founded

2020

Investments made

P

Pluriomics raised $60M on November 16, 2021

Investors: Kiniciti

FAQ